Comparing long-term outcomes of primary and progressive carcinoma invading bladder muscle after radical cystectomy-Reference-Cited by-同舟云学术

Comparing long-term outcomes of primary and progressive carcinoma invading bladder muscle after radical cystectomy

Published:2015-06-03 Issue:4 Volume:117 Page:604-610
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Moschini Marco¹²,Sharma Vidit³,Dell'oglio Paolo¹,Cucchiara Vito¹,Gandaglia Giorgio¹,Cantiello Francesco²,Zattoni Fabio⁴,Pellucchi Federico⁵,Briganti Alberto¹,Damiano Rocco²,Montorsi Francesco¹,Salonia Andrea¹,Colombo Renzo¹

Affiliation:

1. Department of Urology; Urological Research Institute; San Raffaele Scientific Institute; Vita-Salute University; Milan Italy

2. Doctorate Research Program; Magna Graecia University of Catanzaro; Catanzaro Italy

3. Department of Urology; Mayo Clinic Rochester; Rochester MN USA

4. Department of Urology; University of Padua; Padua Italy

5. Department of Urology; Papa Giovanni XXIII Hospital; Bergamo Italy

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.13146/fullpdf

Reference31 articles.

1. Cancer statistics, 2014;Siegel;CA Cancer J Clin,2014

2. EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines;Witjes;Eur Urol,2014

3. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium;Shariat;J Urol,2006

4. Conditional survival of patients with urothelial carcinoma of the urinary bladder treated with radical cystectomy;Sun;Eur J Cancer,2012

5. Impact of preoperative thrombocytosis on pathological outcomes and survival in patients treated with radical cystectomy for bladder carcinoma;Moschini;Anticancer Res,2014

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathologic and survival outcomes following radical cystectomy for “progressive” and “de novo” muscle-invasive bladder cancer: A meta-analysis stratified by neoadjuvant chemotherapy status;Urologic Oncology: Seminars and Original Investigations;2024-10

2. Radiotherapy plus pembrolizumab for advanced urothelial carcinoma: results from the ARON-2 real-world study;Scientific Reports;2024-08-27

3. European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)—A Summary of the 2024 Guidelines Update;European Urology;2024-08

4. Development and validation of a nomogram to predict lymph node metastasis in patients with progressive muscle-invasive bladder cancer;Frontiers in Oncology;2024-05-16

5. The predictive value of PFKFB3 in bladder cancer prognosis;Heliyon;2024-05